UW study examines potential treatment for Alzheimer’s disease
Researchers at the University of Wisconsin School of Medicine and Public Health are investigating whether the drug leuprolide, which is approved for prostate cancer in men, can be used to treat symptoms of Alzheimer’s disease in women.
UW study seeks IBD patients to study effectiveness of updated COVID-19 vaccines
Researchers at the University of Wisconsin School of Medicine and Public Health are investigating how well the updated monovalent COVID-19 vaccines work for inflammatory bowel disease patients.
New gene-editing technique holds potential for treating childhood blindness
Using a new experimental technique to fix faulty eye cells, a team led by UW–Madison researchers was able to repair a gene mutation that causes one form of childhood blindness. The scientists showed that their approach worked in lab-grown cells derived from a patient with the currently untreatable inherited disease Leber congenital amaurosis (LCA) and a mouse model that mimics the disease.
Study explores midlife factors associated with blood biomarkers of neurodegeneration and Alzheimer’s disease
Lifestyle and chronic health conditions in middle age, along with a person’s education level, show associations with emerging blood markers of neurodegeneration and Alzheimer’s disease, according to a new study by researchers at the University of Wisconsin School of Medicine and Public Health.
Nursing home residents benefit from rapid flu testing
Rapid on-site testing of nursing home residents for influenza allowed earlier detection of outbreaks, faster treatment with antiviral medication and much lower hospitalization rates, according to a new study from researchers at the University of Wisconsin School of Medicine and Public Health.
Clinical trial for severe dry mouth treatment launching soon at UW
The UW Health | Carbone Cancer Center and UW Program for Advanced Cell Therapy, or PACT, will soon begin a clinical trial using a recently developed cell therapy to treat severe dry mouth, which is a significant symptom of graft-versus-host disease and Sjögren’s disease.
UW Carbone Cancer Center receives SPORE designation, federal grant to support prostate cancer research
University of Wisconsin Carbone Cancer Center will be designated as a Specialized Program of Research Excellence, or SPORE, by the National Cancer Institute (NCI) for research initiatives to advance new prostate cancer treatments.
UW Health, UW School of Medicine and Public Health launch UW Clinical Trials Institute
UW Health and the UW School of Medicine and Public Health are announcing the formation of the University of Wisconsin Clinical Trials Institute to advance health care innovations via clinical trials at UW–Madison.
Survey highlights changes in Wisconsinites’ alcohol consumption during COVID-19 pandemic
A new survey from the University of Wisconsin School of Medicine and Public Health details which populations experienced the greatest change in alcohol use during the COVID-19 pandemic, finding that higher-earning younger adults increased drinking the most.
Ed Chapman’s tenacious approach to the “most important” problems in biology
No matter how obscure his latest study of fundamental nervous processes might seem, Ed Chapman will try to ease people’s minds.
UW study details how HPV may promote head and neck cancer
Cancer researchers have long known that the sexually transmitted human papillomavirus (HPV) is a leading cause of head and neck cancer and now a study from the University of Wisconsin School of Medicine and Public Health sheds light on how HPV turns healthy cells into cancer.
UW–Madison joins national harm reduction research network to prevent overdose deaths
To build upon existing research and develop new strategies in harm reduction, the National Institutes of Health (NIH) has established a national research network to evaluate harm reduction services. The network will include a coordinating center and nine research studies at institutions across the country, including at the University of Wisconsin–Madison.